Influence of FDG-PET on Computed Tomography-Based Radiotherapy Planning for Locally Recurrent Nasopharyngeal Carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 5, 2007, Pages 1381-1388

  Zheng, Xiao Kang ^a   Chen, Long Hua ^a   Wang, Quan Shi ^a   Wu, Hu Bing ^a   Wang, Hong Mei ^a   Chen, Yong Qin ^a   Yan, Wei Pin ^a   Li, Qi Sheng ^a   Xu, Yi Kai ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

FDG PET; Nasopharyngeal carcinoma; Radiotherapy; Recurrent disease

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DISEASES; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY;

NASOPHARYNGEAL CARCINOMA; RECURRENT DISEASE; RECURRENT NASOPHARYNGEAL CARCINOMA;

RADIOTHERAPY;

FLUORODEOXYGLUCOSE F 18;

ADULT; APPARATUS; ARTICLE; CALCULATION; CHINA; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE; DISEASE SEVERITY; EVALUATION; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RECURRENT CANCER; SIMULATION; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; CYCLIC N-OXIDES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MERCAPTOETHANOL; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36148975717     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.05.033     Document Type: Article

References (28)

1. Zheng X.K., Ma J., Chen L.H., et al. Dosimetric and clinical results of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma. Radiother Oncol 75 (2005) 197-203
2. Ng S.H., Joseph C.T., Chan S.C., et al. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. J Nucl Med 45 (2004) 1669-1676
3. Kao C.H., Tsai S.C., Wang J.J., et al. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy. Cancer 92 (2001) 434-439
4. Kao C.H., Chang Lai S.P., Chieng P.U., et al. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2- deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 16 (1998) 3550-3555
5. Kubota K., Yokoyama J., Yamaguchi K., et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 31 (2004) 590-595
6. Chan S.C., Ng S.H., Chang J.T., et al. Advantages and pitfalls of 18F-fluoro-2-deoxy-d-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: Comparison with magnetic resonance imaging. Eur J Nucl Med Mol Imaging 33 (2006) 1032-1040
7. Yen R.F., Hong R.L., Tzen K.Y., et al. Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma. J Nucl Med 46 (2005) 770-774
8. Tsai M.H., Huang W.S., Tsai J.J., et al. Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomography in patients with indeterminate computed tomography findings. Anticancer Res 23 (2003) 3513-3516
9. Yen R.F., Hung R.L., Pan M.H., et al. 18-Fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging. Cancer 98 (2003) 283-287
10. Tsai M.H., Shiau Y.C., Kao C.H., et al. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy. J Cancer Res Clin Oncol 128 (2002) 279-282
11. Kao C.H., Shiau Y.C., Shen Y.Y., and Yen R.F. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: Comparison with 18-fluoro-2-deoxyglucose positron emission tomography. Cancer 94 (2002) 1981-1986
12. Lowe V.J., Boyd J.H., Dunphy F.R., et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 18 (2000) 651-658
13. Daisne J.F., Duprez T., Weynand B., et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233 (2004) 93-100
14. Paulino A.C., Koshy M., Howell R., et al. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 61 (2005) 1385-1392
15. Riegel A.C., Berson A.M., Destian S., et al. Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion. Int J Radiat Oncol Biol Phys 65 (2006) 726-732
16. Wang D., Schultz C.J., Jursinic P.A., et al. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 143-151
17. Geets X., Daisne J.F., Tomsej M., et al. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: Comparison between pre- and per-treatment studies. Radiother Oncol 78 (2006) 291-297
18. Scarfone C., Lavely W.C., Cmelak A.J., et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med 45 (2004) 543-452
19. Ciernik I.F., Dizendorf E., Baumert B.G., et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study. Int J Radiat Oncol Biol Phys 57 (2003) 853-863
20. 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys 53 (2002) 1051-1057
21. Rahn A.N., Baum R.P., Adamietz I.A., et al. Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors. Strahlenther Onkol 174 (1998) 358-364
22. Takeshi N., Tohru S., Hiroki S., et al. Image fusion between 18-FDG PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys 53 (2002) 1051-1057
23. MacManus M., Hicks R., Bayne M., et al. In regard to Paulino and Johnstone: Use of PET and CT imaging data in radiation therapy planning. (Int J Radiat Oncol Biol Phys 2004;59:4-5) [Letter]. Int J Radiat Oncol Biol Phys 60 (2004) 1005-1006
24. Leong T., Everitt C., Yuen K., et al. A prospective study to evaluate the impact of FDG PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol 78 (2006) 254-261
25. Zheng X.-K., Chen L.-H., Wang Q.-S., and Wu H.-B. Influence of [18] fluorodeoxyglucose positron emission tomography on salvage treatment decision making for locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 1020-1025
26. Nestle U., Kremp S., Schaefer-Schuler A., et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 46 (2005) 1342-1348
27. Wambersie A., and Landberg T. ICRU report 62: Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50) (1999), International Commission on Radiological Units and Measures, Bethesda
28. Fleming ID, Cooper JS, Henson DE, et al., editors, for the American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.